Getting to Know Herbal Medicines and the Basis of Selection for Consumption
09/11/2021 Views : 659
I MADE JAWI
Getting to Know Herbal Medicines and the
Basis of Selection for Consumption
by
Prof. Dr dr. I Made Jawi, M.Kes
Dep. Farmakologi FK Unud
Herbal medicine is defined as raw materials or
preparations derived from plants that have therapeutic effects or other effects
that are beneficial to health. The composition of herbal medicines can be in
the form of crude ingredients, crude extracts or extracts that have been
purified, or processed through certain physical methods. Herbal medicines or
medicinal ingredients from plants, can be consumed directly or used as raw
materials for herbal products, because they contain various types of active
ingredients with medicinal properties. Indonesian herbal medicines have been
used since ancient times as an effort to maintain health, prevent disease and
treat diseases, so their use needs to be encouraged in the community. To ensure
this effort, it is very necessary to increase in-depth understanding of the
classification of herbal medicines and understand the mechanism by which herbal
medicines cause therapeutic effects. The general classification of herbal
medicines are herbal medicine, standardized herbal medicine and
phytopharmaceuticals, each of which has special characteristics.
Jamu is a medicinal preparation of natural
ingredients, the status of safety and efficacy is proven only empirically.
Standardized Herbal Medicines are products
containing ingredients or ingredients in the form of plant ingredients, animal
ingredients, mineral ingredients, sarian (galenic) preparations or mixtures of
these materials which have been used for generations for treatment and can be
applied in accordance with the prevailing norms in society. which have been
scientifically proven safety and efficacy by preclinical testing and
standardized raw materials.
Phytopharmaceuticals are products containing
ingredients or ingredients in the form of plant ingredients, animal ingredients,
mineral ingredients, extract preparations (galenic) or mixtures of these
materials that have been scientifically proven to be safe and effective by
means of preclinical and clinical trials as well as raw materials and finished
products. has been standardized.
In accordance with the Original Indonesian Herbal
Medicine Formulary, the classification of evidence based medicine (EBM)
degrees, herbal medicines are divided into several levels of evidence as
follows:
Herbal Medicines with strong scientific evidence
(Strong Scientific Evidence/Class A).
Evidence of statistically significant benefit from
> 2 eligible randomized control trials (RCTs), or evidence from 1 eligible
RCT and 1 eligible meta-analysis, or evidence from multiple RCTs with the
majority of clinical trials conducted as required , showing evidence of
statistically significant benefit with supporting evidence in basic science,
animal research, or theory.
Herbal Medicines with Good Scientific Evidence
(Group B)
Evidence of statistically significant benefit from
1-2 randomized trials, or evidence of benefit from > 1 eligible
meta-analysis or evidence of benefit from > 1
cohort/case-control/non-randomized clinical trial with supporting evidence in
science
basis, animal research, or theory. This level
applies to situations where a well-designed RCT reports negative results but
contrasts the positive efficacy results resulting from many other poorly
designed clinical trials or well-designed meta-analyses, pending confirmation
of evidence from an additional RCT with good design.
Herbal Medicines with Unclear or Conflicting
Scientific Evidence (Class C)
Evidence of benefit from > 1 small RCT without
adequate sample size, power, significance, or design quality or contentious
evidence from multiple RCTs without the majority of clinical trials meeting
requirements, showing evidence of benefit or ineffectiveness, or evidence of
benefit from > 1 cohort/case-control/clinical trial that was not randomized,
and was not accompanied by supporting evidence in basic science, animal
research, or theory, or evidence of efficacy only from basic science, animal
research, or theory.
Herbal
Medicines with Negative Scientific Evidence (Fair Negative Scientific
Evidence/Group D)
Evidence of no statistically significant benefit
(not proven to be useful) from non-randomized cohorts/case-control/clinical
trials, and evidence from basic science, animal studies, or theory, suggests no
benefit. This level also applies to situations where > 1 well-designed RCT reported
negative results, even though positive efficacy results were reported by
clinical trials or poorly designed meta-analyses.
Herbal Medicines with Very Negative Scientific
Evidence (Strong Negative Scientific Evidence/Class E)
Statistical evidence was not significant (not proven
to be useful) from >1 RCTs with objective criteria of adequate power and
high quality design.
Herbal Medicines No Evidence (Lack of Evidence /
Group F)
Unable to evaluate efficacy because adequate human
data are not available
Understanding the grouping of herbal medicines will
guide us in selecting rational herbal medicines so that they can produce
therapeutic effects as expected. The selection of herbal medicine in the form
of herbal medicine Jamu needs to be careful because it has not been
supported by scientific research, even though it has been used for generations.
Standardized herbal medicine or phytopharmaceuticals are certainly better,
especially if there have been good clinical trials or classified as A or B.
Good luck.